Development and validation of an HPLC-UV method for quantification of elvitegravir and two other new antiretrovirals, dolutegravir and rilpivirine, in the plasma of HIV-positive patients
about
Development and validation of an HPLC-UV method for quantification of elvitegravir and two other new antiretrovirals, dolutegravir and rilpivirine, in the plasma of HIV-positive patients
description
scientific article published on 04 May 2018
@en
name
Development and validation of ...... lasma of HIV-positive patients
@en
type
label
Development and validation of ...... lasma of HIV-positive patients
@en
prefLabel
Development and validation of ...... lasma of HIV-positive patients
@en
P2093
P356
P1476
Development and validation of ...... lasma of HIV-positive patients
@en
P2093
Adriana Ammassari
Andrea Antinori
Anna Loredana Gallo
Leopoldo P Pucillo
Simone Fazio
Stefania Cicalini
P356
10.1002/BMC.4274
P577
2018-05-04T00:00:00Z